4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
CK Life Sciences Int'l., (Holdings) Inc. (0775) operates in the Biotechnology industry and is headquartered in Tai Po, Hong Kong with about 1,920 employees. Its market capitalization is roughly HKD 6 billion. In the fiscal year ended 2025-12-31, 0775 reported HKD 5.4B in revenue and (HKD 187M) in net income.
CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, and sells health and agriculture-related products in the Asia Pacific and North America.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | HKD 5.4B | HKD 5.5B | HKD 5.3B | HKD 5.3B |
| Gross Profit | HKD 1.6B | HKD 1.7B | HKD 1.6B | HKD 1.6B |
| Operating Income (EBIT) | (HKD 131M) | HKD 78M | HKD 224M | HKD 242M |
| Net Income | (HKD 187M) | (HKD 127M) | HKD 17M | HKD 132M |
HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | — | — | (HKD 77M) | (HKD 96M) | (HKD 96M) |
HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | HKD 11.8B | HKD 10.8B | HKD 11.2B | HKD 11.3B | — |
| Total Liabilities | HKD 8.0B | HKD 7.3B | HKD 7.1B | HKD 7.1B | — |
HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0775 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms